Of the cases with clinical data available, ALK-positive lung cancers were associated with younger age compared with the common driver mutation group (p = 0.023, Table 1), but age in ALK-positive group was not significantly difference from the pan-negative group (p = 0.83, Table 1). The gene discussed is ALK; the disease is lung carcinoma.